Nucleai

Nucleai is an artificial intelligence company in Tel Aviv, Israel, founded in 2017. It has raised $47.0M across 2 rounds, most recently a $14.0M Series C in April 2024.

AI-Driven Spatial Biomarkers

Headquarters
Tel Aviv
Employees
51–200
Founded
2017
Business Model
B2B
Website
nucleai.ai
Total Funding
$47.0M
Last Round
$14.0M Series CApr 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Nucleai brings specialized expertise in AI-driven spatial biology and tissue analytics, including proprietary computational approaches for analyzing complex tumor microenvironments at scale. The company partners with academic and pharmaceutical organizations, including the University of Glasgow, to help translate spatial biology insights into clinical practice and drug development.

Summary

It lists 51–200 employees. It has raised $47.0M in total across 2 rounds, most recently a $14.0M Series C round in Apr 2024. Investors include Section 32, M Ventures and Sanofi Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries CApr 2024
$14.0M

Sign up to see all 2 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nucleai on Indexed.vc
<a href="https://indexed.vc/companies/nucleai"><img src="https://indexed.vc/api/badge/company/nucleai" alt="Nucleai on Indexed.vc" width="260" height="76" /></a>